Executive Insights Life Sciences & Pharma Oncology BD&L: Winning in an Increasingly Competitive Environment September 12, 2024
Podcast Life Sciences & Pharma A New Generation of Drug Therapies Requires New Business Strategies July 10, 2024
Case Study Life Sciences & Pharma Value Story and Cross-Stakeholder Action Plan for Oncology Reimbursement May 8, 2024 A big pharma company wanted to enable change in payer attitudes to increase the acceptance of patient-reported outcomes (PROs) and of endpoints beyond…
Case Study Life Sciences & Pharma Cost and Reimbursement Assessment for a Biopharmaceutical Company May 7, 2024 A large biopharmaceutical company developing chimeric antigen receptor T-cell (CAR-T) therapies
